{"gene":"SP9","run_date":"2026-04-28T20:42:08","timeline":{"discoveries":[{"year":2004,"finding":"SP9 (and SP8) are expressed in the apical ectodermal ridge (AER) and act as positive transcriptional regulators of Fgf8 expression, thereby controlling limb outgrowth; they function downstream of Fgf10 signaling from the mesenchyme. Dominant-negative overexpression in chick and morpholino knockdown in zebrafish both abolished Fgf8 expression and disrupted limb outgrowth.","method":"Embryological/genetic analysis, chick overexpression and dominant-negative assays, zebrafish morpholino knockdown, in situ hybridization","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal loss-of-function approaches (dominant-negative + morpholino) in two vertebrate models, replicated with gain-of-function, confirmed target gene regulation","pmids":["15358670"],"is_preprint":false},{"year":2016,"finding":"SP9 is required for the development of striatopallidal (D2-type) MSNs: Sp9-null mice lose most striatopallidal MSNs due to decreased proliferation of their progenitors and increased Bax-dependent apoptosis, while striatonigral neurons are largely unaffected. ChIP-qPCR showed Ascl1 directly binds the Sp9 promoter, placing SP9 downstream of Ascl1. RNA-seq identified Adora2a, P2ry1, Gpr6, and Grik3 as SP9 transcriptional targets.","method":"Sp9 null mouse genetics (KO), ChIP-qPCR, RNA-seq, in situ hybridization","journal":"Cell Reports","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype, epistasis (Bax-dependent apoptosis), ChIP-qPCR for upstream regulator binding, RNA-seq for downstream targets","pmids":["27452460"],"is_preprint":false},{"year":2018,"finding":"SP8 and SP9 coordinately drive expression of the transcription factor Six3 in a spatially restricted domain of the LGE subventricular zone; SP9 directly binds the promoter and a putative enhancer of Six3 (shown by ChIP-Seq). Loss of both SP8 and SP9 (conditional double KO) eliminates virtually all D2 MSNs through reduced neurogenesis, phenocopied by conditional Six3 deletion.","method":"Conditional double knockout mouse genetics, ChIP-Seq, RNA-seq, in situ hybridization","journal":"Development","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP-Seq identifies direct SP9 binding to Six3 regulatory elements; genetic epistasis confirmed by Six3 conditional KO phenocopying double mutant","pmids":["29967281"],"is_preprint":false},{"year":2018,"finding":"SP8 and SP9 coordinately regulate olfactory bulb (OB) interneuron development; conditional double deletion (Sp8/Sp9) causes severe reduction of OB interneurons due to defects in neuronal differentiation, tangential and radial migration, and increased cell death. RNA-Seq revealed that Prokr2 and Tshz1 expression in newly born neuroblasts is dependent on SP8/SP9.","method":"Conditional single and double knockout mouse genetics, RNA-seq, in situ hybridization, cell death assays","journal":"Cerebral Cortex","confidence":"High","confidence_rationale":"Tier 2 — clean single and double KO with multiple defined cellular phenotypes and RNA-Seq identification of downstream targets","pmids":["28981617"],"is_preprint":false},{"year":2019,"finding":"SP9 controls the development of MGE-derived cortical interneurons: Sp9 null and conditional mutant mice show ~50% reduction of MGE-derived cortical interneurons, ectopic aggregation of MGE-derived neurons in the embryonic ventral telencephalon, and an increased SST+/PV+ ratio. SP9 ChIP-Seq and RNA-Seq show SP9 directly regulates key transcription factors (Arx, Lhx6, Lhx8, Nkx2-1, Zeb2) and migration genes (Ackr3, Epha3, St18).","method":"Sp9 null and conditional knockout mice, SP9 ChIP-Seq, RNA-Seq, in situ hybridization","journal":"Cerebral Cortex","confidence":"High","confidence_rationale":"Tier 1–2 — SP9 ChIP-Seq identifies direct targets; multiple KO models with defined phenotypes and multiple downstream genes validated","pmids":["29878134"],"is_preprint":false},{"year":2019,"finding":"SP8 and SP9 coordinately regulate CGE-derived cortical interneuron development and migration; conditional Sp8/Sp9 double KO (Gsx2-Cre and Dlx5/6-CIE) causes severe loss and migration defects (longer leading processes, ectopic accumulation in CGE). SP8/SP9 regulate this in part by repressing Pak3, Robo1, and Slit1 expression.","method":"Conditional double knockout mice (Gsx2-Cre; Dlx5/6-CIE), RNA-seq, in situ hybridization, morphological analysis","journal":"Journal of Comparative Neurology","confidence":"High","confidence_rationale":"Tier 2 — two independent Cre lines for conditional double KO, multiple defined phenotypes, RNA-seq identifies repressed migration gene targets","pmids":["31070778"],"is_preprint":false},{"year":2019,"finding":"SP8 and SP9 coordinately regulate MGE-derived cortical interneuron migration; SP8/SP9 double conditional KO causes severe loss of PV+ cortical interneurons due to tangential migration defects. SP8/SP9 regulate migration at least in part through EphA3, Ppp2r2c, and Rasgef1b expression.","method":"Sp8/Sp9 double conditional knockout mice, immunohistochemistry, gene expression analysis","journal":"Frontiers in Molecular Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — conditional double KO with defined migration phenotype, but downstream target validation is less rigorous than ChIP-Seq confirmation","pmids":["31001083"],"is_preprint":false},{"year":2022,"finding":"SP9 acts as a negative regulator of D1-MSN identity: sustained Sp9 expression in LGE progenitors promotes D2-MSN identity and represses D1-MSN identity, causing an imbalance between D1- and D2-MSNs. Sp9-positive progenitors produce both D1- and D2-MSNs, but Sp9 expression is rapidly downregulated in postmitotic D1-MSNs.","method":"Gain-of-function (sustained Sp9 expression in LGE progenitors), lineage tracing, immunohistochemistry in mouse","journal":"Cell Death Discovery","confidence":"Medium","confidence_rationale":"Tier 2 — defined gain-of-function with specific cell fate phenotype, but mechanism of repression is not molecularly resolved","pmids":["35773249"],"is_preprint":false},{"year":2024,"finding":"De novo heterozygous SP9 variants cause human interneuronopathy. Missense variants affecting glutamate 378 in the DNA-binding domain have hypomorphic and neomorphic DNA-binding effects (causing severe epileptic encephalopathy), while loss-of-function variants produce a milder neurodevelopmental phenotype. In vitro assays confirmed altered DNA-binding properties of these variants.","method":"Human genetics (de novo variant identification), in silico analysis, in vitro DNA-binding assays","journal":"Genetics in Medicine","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro functional validation of DNA-binding effects of specific variants; human patient data corroborates functional mechanism","pmids":["38288683"],"is_preprint":false},{"year":2025,"finding":"SP9 is identified as a key regulator of visual thalamic fate during mouse thalamus development, established through in silico predictions from single-cell multiomic atlas and confirmed by in vivo perturbations.","method":"Single-cell multiomics, spatial transcriptomics, lineage tracing, in vivo perturbation in mouse","journal":"bioRxiv (preprint)","confidence":"Low","confidence_rationale":"Tier 3 — preprint, in vivo perturbation details not fully described in abstract; single study","pmids":["bio_10.1101_2025.07.17.665342"],"is_preprint":true}],"current_model":"SP9 is a zinc-finger transcription factor (KLF/SP family) that directly binds regulatory DNA elements to control the development, differentiation, migration, and survival of multiple neuronal subtypes—including striatopallidal D2 MSNs (where it promotes D2 and represses D1 identity), MGE- and CGE-derived cortical interneurons, and olfactory bulb interneurons—acting downstream of Ascl1 and upstream of transcriptional cascades including Six3, Lhx6, Arx, and Nkx2-1, while also functioning earlier in vertebrate embryogenesis to regulate Fgf8 expression and limb outgrowth downstream of Fgf10 signaling."},"narrative":{"teleology":[{"year":2004,"claim":"Before any neuronal role was known, SP9 was established as a transcriptional activator of Fgf8 in the apical ectodermal ridge, linking it to Fgf10-dependent limb outgrowth and demonstrating its capacity to directly regulate signaling gene expression in embryonic development.","evidence":"Dominant-negative overexpression in chick and morpholino knockdown in zebrafish, both abolishing Fgf8 expression and limb outgrowth","pmids":["15358670"],"confidence":"High","gaps":["Whether SP9 directly binds Fgf8 regulatory elements was not resolved","Role in mammalian limb development not tested"]},{"year":2016,"claim":"SP9 was found to be essential for striatopallidal (D2-type) MSN development, establishing its first brain-specific function: Sp9-null mice lost most D2-MSNs through reduced progenitor proliferation and Bax-dependent apoptosis, placing SP9 downstream of Ascl1 and upstream of D2-MSN identity genes such as Adora2a.","evidence":"Sp9 knockout mice, ChIP-qPCR showing Ascl1 binding at Sp9 promoter, RNA-seq identifying downstream targets","pmids":["27452460"],"confidence":"High","gaps":["Whether SP9 directly binds the promoters of D2 identity genes was not shown at this stage","Mechanism by which SP9 promotes proliferation vs. suppresses apoptosis not distinguished"]},{"year":2018,"claim":"SP9 was shown to directly bind and activate Six3, a transcription factor essential for D2-MSN neurogenesis, revealing a direct transcriptional cascade (SP9→Six3) for striatal neuron specification, with SP8/SP9 double knockout phenocopied by Six3 conditional deletion.","evidence":"SP9 ChIP-Seq identifying binding at Six3 promoter and enhancer; conditional double KO and Six3 conditional KO in mouse","pmids":["29967281"],"confidence":"High","gaps":["Whether Six3 is the sole critical mediator or one of several parallel SP9 effectors in D2-MSN specification remains open"]},{"year":2018,"claim":"The cooperative role of SP8 and SP9 was extended to olfactory bulb interneuron development, demonstrating that SP9 controls neuronal differentiation, tangential and radial migration, and survival of OB interneurons through targets including Prokr2 and Tshz1.","evidence":"Conditional single and double knockout mice, RNA-seq, cell death assays","pmids":["28981617"],"confidence":"High","gaps":["Direct binding of SP9 to Prokr2 and Tshz1 regulatory regions not confirmed by ChIP","Relative contributions of SP8 vs SP9 not fully dissected"]},{"year":2019,"claim":"SP9 was established as a direct transcriptional regulator of cortical interneuron development from both the MGE and CGE: ChIP-Seq identified direct SP9 binding at Arx, Lhx6, Nkx2-1, and migration effector genes, while loss of SP9 caused ~50% reduction of MGE-derived interneurons and severe migration defects in CGE-derived interneurons.","evidence":"Sp9 null and conditional KO mice; SP9 ChIP-Seq and RNA-Seq for MGE; Sp8/Sp9 double conditional KO with two independent Cre lines for CGE","pmids":["29878134","31070778","31001083"],"confidence":"High","gaps":["How SP9 differentially regulates PV vs SST interneuron fate is not resolved","Whether repression of Pak3/Robo1/Slit1 in CGE is through direct SP9 binding or indirect"]},{"year":2022,"claim":"SP9 was shown to actively repress D1-MSN identity, not merely promote D2-MSN fate, clarifying it as a binary fate switch: sustained SP9 expression in LGE progenitors biased output toward D2-MSNs at the expense of D1-MSNs.","evidence":"Gain-of-function (sustained Sp9 expression in LGE progenitors) with lineage tracing in mouse","pmids":["35773249"],"confidence":"Medium","gaps":["Molecular mechanism of D1-MSN identity repression (direct targets silenced) is not identified","Whether SP9 downregulation in postmitotic D1-MSNs is instructive or permissive is unresolved"]},{"year":2024,"claim":"Translation to human disease was achieved: de novo SP9 variants were shown to cause interneuronopathy, with missense variants at Glu378 in the DNA-binding domain producing hypomorphic/neomorphic binding and severe epileptic encephalopathy, directly linking SP9 loss-of-function to human neurodevelopmental disease.","evidence":"Human genetic cohort with de novo variant identification; in vitro DNA-binding assays confirming altered function","pmids":["38288683"],"confidence":"Medium","gaps":["Patient cohort size is limited","In vivo modeling of specific human variants has not been performed","Genotype-phenotype correlation across the full mutational spectrum is incomplete"]},{"year":null,"claim":"Key unresolved questions include: the genome-wide direct target repertoire in each neuronal lineage; the structural basis of SP9 DNA-binding specificity compared to SP8; whether SP9 functions in postnatal/adult neuronal maintenance; and the precise mechanism by which SP9 represses D1-MSN identity genes.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal structure or cryo-EM structure of SP9 zinc-finger domain","Postnatal and adult functions of SP9 in neurons not tested","Full genomic binding comparison of SP9 vs SP8 not available"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,2,4,8]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,2,4,7]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,4,8]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,1,2,3,4,5,6,7]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,2,4]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[1,3,4,5,6]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[1,3]}],"complexes":[],"partners":["ASCL1","SP8","SIX3"],"other_free_text":[]},"mechanistic_narrative":"SP9 is a zinc-finger transcription factor of the KLF/SP family that functions as a master regulator of neuronal subtype specification, survival, and migration during vertebrate brain development. It directly binds regulatory elements of key transcription factors—including Six3, Arx, Lhx6, and Nkx2-1—and downstream effector genes to promote D2 medium spiny neuron (MSN) identity while repressing D1-MSN fate in the striatum, and to control the tangential migration and survival of both MGE- and CGE-derived cortical interneurons and olfactory bulb interneurons [PMID:27452460, PMID:29967281, PMID:29878134, PMID:31070778, PMID:35773249]. SP9 operates downstream of Ascl1, which directly binds its promoter, and frequently acts in concert with its paralog SP8 [PMID:27452460, PMID:29967281]. De novo heterozygous SP9 variants affecting its DNA-binding domain cause human interneuronopathy, with missense variants at glutamate 378 producing hypomorphic/neomorphic DNA-binding and severe epileptic encephalopathy, while loss-of-function variants yield a milder neurodevelopmental phenotype [PMID:38288683]."},"prefetch_data":{"uniprot":{"accession":"P0CG40","full_name":"Transcription factor Sp9","aliases":[],"length_aa":484,"mass_kda":48.9,"function":"Transcription factor which plays a key role in limb development. Positively regulates FGF8 expression in the apical ectodermal ridge (AER) and contributes to limb outgrowth in embryos (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P0CG40/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SP9","classification":"Not Classified","n_dependent_lines":30,"n_total_lines":1208,"dependency_fraction":0.024834437086092714},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SP9","total_profiled":1310},"omim":[{"mim_id":"621003","title":"TRANSCRIPTION FACTOR Sp9; SP9","url":"https://www.omim.org/entry/621003"},{"mim_id":"102545","title":"ACTIN, GAMMA-2, SMOOTH MUSCLE, ENTERIC; ACTG2","url":"https://www.omim.org/entry/102545"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Mitochondria","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":3.9},{"tissue":"fallopian tube","ntpm":1.7}],"url":"https://www.proteinatlas.org/search/SP9"},"hgnc":{"alias_symbol":["ZNF990"],"prev_symbol":[]},"alphafold":{"accession":"P0CG40","domains":[{"cath_id":"-","chopping":"308-359","consensus_level":"medium","plddt":65.3306,"start":308,"end":359}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P0CG40","model_url":"https://alphafold.ebi.ac.uk/files/AF-P0CG40-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P0CG40-F1-predicted_aligned_error_v6.png","plddt_mean":48.34},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SP9","jax_strain_url":"https://www.jax.org/strain/search?query=SP9"},"sequence":{"accession":"P0CG40","fasta_url":"https://rest.uniprot.org/uniprotkb/P0CG40.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P0CG40/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P0CG40"}},"corpus_meta":[{"pmid":"15358670","id":"PMC_15358670","title":"Sp8 and Sp9, two closely related buttonhead-like transcription factors, regulate Fgf8 expression and limb outgrowth in vertebrate embryos.","date":"2004","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15358670","citation_count":134,"is_preprint":false},{"pmid":"27452460","id":"PMC_27452460","title":"The Zinc Finger Transcription Factor Sp9 Is Required for the Development of Striatopallidal Projection Neurons.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27452460","citation_count":60,"is_preprint":false},{"pmid":"29967281","id":"PMC_29967281","title":"SP8 and SP9 coordinately promote D2-type medium spiny neuron production by activating Six3 expression.","date":"2018","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/29967281","citation_count":55,"is_preprint":false},{"pmid":"28981617","id":"PMC_28981617","title":"Transcription Factors Sp8 and Sp9 Coordinately Regulate Olfactory Bulb Interneuron Development.","date":"2018","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/28981617","citation_count":54,"is_preprint":false},{"pmid":"29878134","id":"PMC_29878134","title":"Sp9 Regulates Medial Ganglionic Eminence-Derived Cortical Interneuron Development.","date":"2019","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/29878134","citation_count":35,"is_preprint":false},{"pmid":"31070778","id":"PMC_31070778","title":"Transcription factors Sp8 and Sp9 regulate the development of caudal ganglionic eminence-derived cortical interneurons.","date":"2019","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31070778","citation_count":29,"is_preprint":false},{"pmid":"29881660","id":"PMC_29881660","title":"Heliomycin and tetracinomycin D: anthraquinone derivatives with histone deacetylase inhibitory activity from marine sponge-associated Streptomyces sp. SP9.","date":"2018","source":"3 Biotech","url":"https://pubmed.ncbi.nlm.nih.gov/29881660","citation_count":15,"is_preprint":false},{"pmid":"31001083","id":"PMC_31001083","title":"Transcription Factors Sp8 and Sp9 Regulate Medial Ganglionic Eminence-Derived Cortical Interneuron Migration.","date":"2019","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31001083","citation_count":11,"is_preprint":false},{"pmid":"35773249","id":"PMC_35773249","title":"Transcription factor Sp9 is a negative regulator of D1-type MSN development.","date":"2022","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/35773249","citation_count":9,"is_preprint":false},{"pmid":"38501924","id":"PMC_38501924","title":"The in vitro replication phenotype of hepatitis B virus (HBV) splice variants Sp3 and Sp9 and their impact on wild-type HBV replication.","date":"2024","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/38501924","citation_count":7,"is_preprint":false},{"pmid":"37539266","id":"PMC_37539266","title":"Diversity, astaxanthin production, and genomic analysis of Rhodotorula paludigena SP9-15.","date":"2023","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/37539266","citation_count":7,"is_preprint":false},{"pmid":"38288683","id":"PMC_38288683","title":"De novo variants in SP9 cause a novel form of interneuronopathy characterized by intellectual disability, autism spectrum disorder, and epilepsy with variable expressivity.","date":"2024","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38288683","citation_count":3,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.07.17.665342","title":"Early lineage divergence segregates sensory and non-sensory thalamic circuits","date":"2025-07-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.17.665342","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.03.17.643665","title":"Electrical Spinal Imaging (ESI): Analysing spinal cord activity with non-invasive, high-resolution mapping","date":"2025-03-17","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.17.643665","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8153,"output_tokens":2660,"usd":0.032179},"stage2":{"model":"claude-opus-4-6","input_tokens":5975,"output_tokens":2289,"usd":0.13065},"total_usd":0.162829,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"SP9 (and SP8) are expressed in the apical ectodermal ridge (AER) and act as positive transcriptional regulators of Fgf8 expression, thereby controlling limb outgrowth; they function downstream of Fgf10 signaling from the mesenchyme. Dominant-negative overexpression in chick and morpholino knockdown in zebrafish both abolished Fgf8 expression and disrupted limb outgrowth.\",\n      \"method\": \"Embryological/genetic analysis, chick overexpression and dominant-negative assays, zebrafish morpholino knockdown, in situ hybridization\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal loss-of-function approaches (dominant-negative + morpholino) in two vertebrate models, replicated with gain-of-function, confirmed target gene regulation\",\n      \"pmids\": [\"15358670\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"SP9 is required for the development of striatopallidal (D2-type) MSNs: Sp9-null mice lose most striatopallidal MSNs due to decreased proliferation of their progenitors and increased Bax-dependent apoptosis, while striatonigral neurons are largely unaffected. ChIP-qPCR showed Ascl1 directly binds the Sp9 promoter, placing SP9 downstream of Ascl1. RNA-seq identified Adora2a, P2ry1, Gpr6, and Grik3 as SP9 transcriptional targets.\",\n      \"method\": \"Sp9 null mouse genetics (KO), ChIP-qPCR, RNA-seq, in situ hybridization\",\n      \"journal\": \"Cell Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype, epistasis (Bax-dependent apoptosis), ChIP-qPCR for upstream regulator binding, RNA-seq for downstream targets\",\n      \"pmids\": [\"27452460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SP8 and SP9 coordinately drive expression of the transcription factor Six3 in a spatially restricted domain of the LGE subventricular zone; SP9 directly binds the promoter and a putative enhancer of Six3 (shown by ChIP-Seq). Loss of both SP8 and SP9 (conditional double KO) eliminates virtually all D2 MSNs through reduced neurogenesis, phenocopied by conditional Six3 deletion.\",\n      \"method\": \"Conditional double knockout mouse genetics, ChIP-Seq, RNA-seq, in situ hybridization\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP-Seq identifies direct SP9 binding to Six3 regulatory elements; genetic epistasis confirmed by Six3 conditional KO phenocopying double mutant\",\n      \"pmids\": [\"29967281\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SP8 and SP9 coordinately regulate olfactory bulb (OB) interneuron development; conditional double deletion (Sp8/Sp9) causes severe reduction of OB interneurons due to defects in neuronal differentiation, tangential and radial migration, and increased cell death. RNA-Seq revealed that Prokr2 and Tshz1 expression in newly born neuroblasts is dependent on SP8/SP9.\",\n      \"method\": \"Conditional single and double knockout mouse genetics, RNA-seq, in situ hybridization, cell death assays\",\n      \"journal\": \"Cerebral Cortex\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean single and double KO with multiple defined cellular phenotypes and RNA-Seq identification of downstream targets\",\n      \"pmids\": [\"28981617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SP9 controls the development of MGE-derived cortical interneurons: Sp9 null and conditional mutant mice show ~50% reduction of MGE-derived cortical interneurons, ectopic aggregation of MGE-derived neurons in the embryonic ventral telencephalon, and an increased SST+/PV+ ratio. SP9 ChIP-Seq and RNA-Seq show SP9 directly regulates key transcription factors (Arx, Lhx6, Lhx8, Nkx2-1, Zeb2) and migration genes (Ackr3, Epha3, St18).\",\n      \"method\": \"Sp9 null and conditional knockout mice, SP9 ChIP-Seq, RNA-Seq, in situ hybridization\",\n      \"journal\": \"Cerebral Cortex\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — SP9 ChIP-Seq identifies direct targets; multiple KO models with defined phenotypes and multiple downstream genes validated\",\n      \"pmids\": [\"29878134\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SP8 and SP9 coordinately regulate CGE-derived cortical interneuron development and migration; conditional Sp8/Sp9 double KO (Gsx2-Cre and Dlx5/6-CIE) causes severe loss and migration defects (longer leading processes, ectopic accumulation in CGE). SP8/SP9 regulate this in part by repressing Pak3, Robo1, and Slit1 expression.\",\n      \"method\": \"Conditional double knockout mice (Gsx2-Cre; Dlx5/6-CIE), RNA-seq, in situ hybridization, morphological analysis\",\n      \"journal\": \"Journal of Comparative Neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two independent Cre lines for conditional double KO, multiple defined phenotypes, RNA-seq identifies repressed migration gene targets\",\n      \"pmids\": [\"31070778\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SP8 and SP9 coordinately regulate MGE-derived cortical interneuron migration; SP8/SP9 double conditional KO causes severe loss of PV+ cortical interneurons due to tangential migration defects. SP8/SP9 regulate migration at least in part through EphA3, Ppp2r2c, and Rasgef1b expression.\",\n      \"method\": \"Sp8/Sp9 double conditional knockout mice, immunohistochemistry, gene expression analysis\",\n      \"journal\": \"Frontiers in Molecular Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional double KO with defined migration phenotype, but downstream target validation is less rigorous than ChIP-Seq confirmation\",\n      \"pmids\": [\"31001083\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SP9 acts as a negative regulator of D1-MSN identity: sustained Sp9 expression in LGE progenitors promotes D2-MSN identity and represses D1-MSN identity, causing an imbalance between D1- and D2-MSNs. Sp9-positive progenitors produce both D1- and D2-MSNs, but Sp9 expression is rapidly downregulated in postmitotic D1-MSNs.\",\n      \"method\": \"Gain-of-function (sustained Sp9 expression in LGE progenitors), lineage tracing, immunohistochemistry in mouse\",\n      \"journal\": \"Cell Death Discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined gain-of-function with specific cell fate phenotype, but mechanism of repression is not molecularly resolved\",\n      \"pmids\": [\"35773249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"De novo heterozygous SP9 variants cause human interneuronopathy. Missense variants affecting glutamate 378 in the DNA-binding domain have hypomorphic and neomorphic DNA-binding effects (causing severe epileptic encephalopathy), while loss-of-function variants produce a milder neurodevelopmental phenotype. In vitro assays confirmed altered DNA-binding properties of these variants.\",\n      \"method\": \"Human genetics (de novo variant identification), in silico analysis, in vitro DNA-binding assays\",\n      \"journal\": \"Genetics in Medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro functional validation of DNA-binding effects of specific variants; human patient data corroborates functional mechanism\",\n      \"pmids\": [\"38288683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SP9 is identified as a key regulator of visual thalamic fate during mouse thalamus development, established through in silico predictions from single-cell multiomic atlas and confirmed by in vivo perturbations.\",\n      \"method\": \"Single-cell multiomics, spatial transcriptomics, lineage tracing, in vivo perturbation in mouse\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — preprint, in vivo perturbation details not fully described in abstract; single study\",\n      \"pmids\": [\"bio_10.1101_2025.07.17.665342\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"SP9 is a zinc-finger transcription factor (KLF/SP family) that directly binds regulatory DNA elements to control the development, differentiation, migration, and survival of multiple neuronal subtypes—including striatopallidal D2 MSNs (where it promotes D2 and represses D1 identity), MGE- and CGE-derived cortical interneurons, and olfactory bulb interneurons—acting downstream of Ascl1 and upstream of transcriptional cascades including Six3, Lhx6, Arx, and Nkx2-1, while also functioning earlier in vertebrate embryogenesis to regulate Fgf8 expression and limb outgrowth downstream of Fgf10 signaling.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SP9 is a zinc-finger transcription factor of the KLF/SP family that functions as a master regulator of neuronal subtype specification, survival, and migration during vertebrate brain development. It directly binds regulatory elements of key transcription factors—including Six3, Arx, Lhx6, and Nkx2-1—and downstream effector genes to promote D2 medium spiny neuron (MSN) identity while repressing D1-MSN fate in the striatum, and to control the tangential migration and survival of both MGE- and CGE-derived cortical interneurons and olfactory bulb interneurons [PMID:27452460, PMID:29967281, PMID:29878134, PMID:31070778, PMID:35773249]. SP9 operates downstream of Ascl1, which directly binds its promoter, and frequently acts in concert with its paralog SP8 [PMID:27452460, PMID:29967281]. De novo heterozygous SP9 variants affecting its DNA-binding domain cause human interneuronopathy, with missense variants at glutamate 378 producing hypomorphic/neomorphic DNA-binding and severe epileptic encephalopathy, while loss-of-function variants yield a milder neurodevelopmental phenotype [PMID:38288683].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Before any neuronal role was known, SP9 was established as a transcriptional activator of Fgf8 in the apical ectodermal ridge, linking it to Fgf10-dependent limb outgrowth and demonstrating its capacity to directly regulate signaling gene expression in embryonic development.\",\n      \"evidence\": \"Dominant-negative overexpression in chick and morpholino knockdown in zebrafish, both abolishing Fgf8 expression and limb outgrowth\",\n      \"pmids\": [\"15358670\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SP9 directly binds Fgf8 regulatory elements was not resolved\", \"Role in mammalian limb development not tested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"SP9 was found to be essential for striatopallidal (D2-type) MSN development, establishing its first brain-specific function: Sp9-null mice lost most D2-MSNs through reduced progenitor proliferation and Bax-dependent apoptosis, placing SP9 downstream of Ascl1 and upstream of D2-MSN identity genes such as Adora2a.\",\n      \"evidence\": \"Sp9 knockout mice, ChIP-qPCR showing Ascl1 binding at Sp9 promoter, RNA-seq identifying downstream targets\",\n      \"pmids\": [\"27452460\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SP9 directly binds the promoters of D2 identity genes was not shown at this stage\", \"Mechanism by which SP9 promotes proliferation vs. suppresses apoptosis not distinguished\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"SP9 was shown to directly bind and activate Six3, a transcription factor essential for D2-MSN neurogenesis, revealing a direct transcriptional cascade (SP9→Six3) for striatal neuron specification, with SP8/SP9 double knockout phenocopied by Six3 conditional deletion.\",\n      \"evidence\": \"SP9 ChIP-Seq identifying binding at Six3 promoter and enhancer; conditional double KO and Six3 conditional KO in mouse\",\n      \"pmids\": [\"29967281\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Six3 is the sole critical mediator or one of several parallel SP9 effectors in D2-MSN specification remains open\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The cooperative role of SP8 and SP9 was extended to olfactory bulb interneuron development, demonstrating that SP9 controls neuronal differentiation, tangential and radial migration, and survival of OB interneurons through targets including Prokr2 and Tshz1.\",\n      \"evidence\": \"Conditional single and double knockout mice, RNA-seq, cell death assays\",\n      \"pmids\": [\"28981617\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding of SP9 to Prokr2 and Tshz1 regulatory regions not confirmed by ChIP\", \"Relative contributions of SP8 vs SP9 not fully dissected\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"SP9 was established as a direct transcriptional regulator of cortical interneuron development from both the MGE and CGE: ChIP-Seq identified direct SP9 binding at Arx, Lhx6, Nkx2-1, and migration effector genes, while loss of SP9 caused ~50% reduction of MGE-derived interneurons and severe migration defects in CGE-derived interneurons.\",\n      \"evidence\": \"Sp9 null and conditional KO mice; SP9 ChIP-Seq and RNA-Seq for MGE; Sp8/Sp9 double conditional KO with two independent Cre lines for CGE\",\n      \"pmids\": [\"29878134\", \"31070778\", \"31001083\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How SP9 differentially regulates PV vs SST interneuron fate is not resolved\", \"Whether repression of Pak3/Robo1/Slit1 in CGE is through direct SP9 binding or indirect\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"SP9 was shown to actively repress D1-MSN identity, not merely promote D2-MSN fate, clarifying it as a binary fate switch: sustained SP9 expression in LGE progenitors biased output toward D2-MSNs at the expense of D1-MSNs.\",\n      \"evidence\": \"Gain-of-function (sustained Sp9 expression in LGE progenitors) with lineage tracing in mouse\",\n      \"pmids\": [\"35773249\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism of D1-MSN identity repression (direct targets silenced) is not identified\", \"Whether SP9 downregulation in postmitotic D1-MSNs is instructive or permissive is unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Translation to human disease was achieved: de novo SP9 variants were shown to cause interneuronopathy, with missense variants at Glu378 in the DNA-binding domain producing hypomorphic/neomorphic binding and severe epileptic encephalopathy, directly linking SP9 loss-of-function to human neurodevelopmental disease.\",\n      \"evidence\": \"Human genetic cohort with de novo variant identification; in vitro DNA-binding assays confirming altered function\",\n      \"pmids\": [\"38288683\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Patient cohort size is limited\", \"In vivo modeling of specific human variants has not been performed\", \"Genotype-phenotype correlation across the full mutational spectrum is incomplete\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the genome-wide direct target repertoire in each neuronal lineage; the structural basis of SP9 DNA-binding specificity compared to SP8; whether SP9 functions in postnatal/adult neuronal maintenance; and the precise mechanism by which SP9 represses D1-MSN identity genes.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal structure or cryo-EM structure of SP9 zinc-finger domain\", \"Postnatal and adult functions of SP9 in neurons not tested\", \"Full genomic binding comparison of SP9 vs SP8 not available\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 2, 4, 8]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 2, 4, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 4, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1, 2, 3, 4, 5, 6, 7]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 2, 4]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [1, 3, 4, 5, 6]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [1, 3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ASCL1\", \"SP8\", \"SIX3\"],\n    \"other_free_text\": []\n  }\n}\n```"}